Effect of short-term vitamin (folic acid, vitamins B6 and B12) administration on endothelial dysfunction induced by post-methionine load hyperhomocysteinemia

American Journal of Cardiology

Volumn 84, Issue 11, 1999, Pages 1359-1361

  Chao, Chia Lun ^a   Chien, Kuo Liong ^a   Lee, Yuan Teh ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID ANTAGONIST; HOMOCYSTEINE; METHIONINE; PYRIDOXINE;

ADULT; ARTICLE; BRACHIAL ARTERY; CONTROLLED STUDY; DRUG EFFECT; DRUG INDUCED DISEASE; ECHOGRAPHY; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPERHOMOCYSTEINEMIA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASODILATATION;

ADMINISTRATION, ORAL; ADULT; BLOOD FLOW VELOCITY; DRUG THERAPY, COMBINATION; ENDOTHELIUM, VASCULAR; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHIONINE; MIDDLE AGED; PYRIDOXINE; TREATMENT OUTCOME; VASODILATION; VITAMIN B 12;

EID: 0032703860     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00575-5     Document Type: Article

References (20)

1. Woo K.S., Chook P., Lolin Y.I., Cheung A.S.P., Chan L.T., Sun Y.Y., Sanderson J.E., Metreweli C., Celermajer D.S. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. Circulation. 96:1997;2542-2544.
2. Tawakol A., Omland T., Gerhard M., Wu J.T., Creager M.A. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation. 95:1997;1119-1121.
3. Chambers J.C., McGregor A., Jean-Marie J., Kooner J.S. Acute hyperhomocysteinaemia and endothelial dysfunction. Lancet. 351:1998;36-37.
4. Bellamy M.F., McDowell I.F.W., Ramsey M.W., Brownlee M., Bones C., Mnewcombe R.G., Lewis M.J. Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults. Circulation. 98:1998;1848-1852.
5. Brattström L. Vitamins as homocysteine-lowering agents. J Nutr. 126:1996;1276S-1280S.
6. Van den Berg M., Boers G.H.J. Homocystinuria what about mild hyperhomocysteinaemia? Postgrad Med J. 72:1996;513-518.
7. Shipchandler M.T., Moore E.G. Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott IMx analyzer. Clin Chem. 41:1995;991-994.
8. Celermajer D.S., Sorensen K.E., Gooch V.M., Spiegelhalter D.J., Miller O.I., Sullivan I.D., Lloyd J.K., Deanfield J.E. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 340:1992;1111-1115.
9. Ueland P.M., Refsum H., Stabler S.P., Malinow M.R., Andersson A., Allen R.H. Total homocysteine in plasma or serum methods and clinical applications . Clin Chem. 39:1993;1764-1779.
10. Boushey C.J., Beresford S.A.A., Omenn G.S., Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease probable benefits of increasing folic acid intakes . JAMA. 274:1995;1049-1057.
11. Graham I.M., Daly L.E., Refsum H.M., Robinson K., Brattström L.E., Ueland P.M., Palma-Reis R.J., Boers G.H.J., Sheahan R.G., Israelsson B., et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA. 277:1997;1775-1781.
12. Ross R. The pathogenesis of atherosclerosis a perspective for the 1990's . Nature. 362:1993;801-809.
13. Wall R.T., Harlan J.M., Harker L.A., Striker G.E. Homocysteine-induced endothelial cell injury in vitro a model for the study of vascular injury . Thromb Res. 18:1980;113-121.
14. Stamler J.S., Osborne J.A., Jaraki O., Rabbani L.E., Mullins M., Singel D., Loscalzo J. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest. 91:1993;308-318.
15. Bellamy M.F., McDowell I.F.W. Putative mechanisms for vascular damage by homocysteine. J Inher Metab Dis. 20:1997;307-315.
16. Starkebaum G., Harlan J.M. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest. 77:1986;1370-1376.
17. Loscalzo J. The oxidant stress of hyperhomocysteinaemia. J Clin Invest. 98:1996;5-7.
18. Kang S.-S., Wong P.W.K., Malinow M.R. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu Rev Nutr. 12:1992;279-298.
19. Mayer E.L., Jacobsen D.W., Robinson K. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol. 27:1996;517-527.
20. Usui M., Matsuoka H., Miyazaki H., Ueda S., Okuda S., Imaizumi T. Endothelial dysfunction by acute hyperhomocyst(e)inaemia restoration by folic acid . Clin Sci. 96:1999;235-239.